European regulators have validated the marketing authorisation application for Shire’s experimental von Willebrand Disease therapy Veyvondi.
An experimental therapy being developed by Amgen and Novartis to prevent migraine has been accepted for review in the European Union.
Aspen Pharmacare is under investigation by the European Commission over its pricing practices for five cancer medicines.
Go to Page
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.
Copyright © 2016-2018 Drugdu.com. All Rights Reserved.